Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHE:002399)
China
· Delayed Price · Currency is CNY 11.34
-0.36 (-3.08%)
Feb 28, 2025, 2:45 PM CST
SHE:002399 Revenue
Shenzhen Hepalink Pharmaceutical Group had revenue of 1.23B CNY in the quarter ending September 30, 2024, a decrease of -8.80%. This brings the company's revenue in the last twelve months to 5.45B, down -6.46% year-over-year. In the year 2023, Shenzhen Hepalink Pharmaceutical Group had annual revenue of 5.45B, down -23.94%.
Revenue (ttm)
5.45B
Revenue Growth
-6.46%
P/S Ratio
3.05
Revenue / Employee
2.62M
Employees
2,080
Market Cap
15.05B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 5.45B | -1.71B | -23.94% |
| Jan 1, 2023 | 7.16B | 794.23M | 12.48% |
| Jan 1, 2022 | 6.37B | 1.03B | 19.38% |
| Dec 31, 2020 | 5.33B | 707.42M | 15.30% |
| Dec 31, 2019 | 4.62B | -190.31M | -3.95% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| Jiangsu Hengrui Medicine | 26.00B |
| WuXi AppTec | 38.50B |
| Aier Eye Hospital Group | 20.62B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
| Shanghai United Imaging Healthcare | 10.93B |
| Yunnan Baiyao Group Co.,Ltd | 39.34B |
| Sichuan Biokin Pharmaceutical | 5.85B |